MXPA04004132A - Hexa-, hepta-, y octapeptidos que tienen actividad antiangiogenica. - Google Patents

Hexa-, hepta-, y octapeptidos que tienen actividad antiangiogenica.

Info

Publication number
MXPA04004132A
MXPA04004132A MXPA04004132A MXPA04004132A MXPA04004132A MX PA04004132 A MXPA04004132 A MX PA04004132A MX PA04004132 A MXPA04004132 A MX PA04004132A MX PA04004132 A MXPA04004132 A MX PA04004132A MX PA04004132 A MXPA04004132 A MX PA04004132A
Authority
MX
Mexico
Prior art keywords
octapeptides
hepta
hexa
antiangiogenic activity
compounds
Prior art date
Application number
MXPA04004132A
Other languages
English (en)
Inventor
Haviv Fortuna
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MXPA04004132A publication Critical patent/MXPA04004132A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describe los compuestos de la formula (SEQ ID NO:1), los cuales con utiles para tratar las condiciones que se originan de o se exacerban por angiogenesis. Tambien se describen las composiciones farmaceuticas que comprenden estos compuestos, los metodos de tratamiento que utilizan estos compuestos, y los metodos para inhibir la angiogegesis.
MXPA04004132A 2001-10-31 2002-10-30 Hexa-, hepta-, y octapeptidos que tienen actividad antiangiogenica. MXPA04004132A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/000,633 US20030119746A1 (en) 2001-10-31 2001-10-31 Hepta-and octapeptides having antiangiogenic activity
PCT/US2002/034812 WO2003065974A2 (en) 2001-10-31 2002-10-30 Hexa-, hepta-, and octapeptides having antiangiogenic activity

Publications (1)

Publication Number Publication Date
MXPA04004132A true MXPA04004132A (es) 2004-07-08

Family

ID=21692353

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004132A MXPA04004132A (es) 2001-10-31 2002-10-30 Hexa-, hepta-, y octapeptidos que tienen actividad antiangiogenica.

Country Status (6)

Country Link
US (1) US20030119746A1 (es)
EP (1) EP1461356A4 (es)
JP (1) JP2005517691A (es)
CA (1) CA2466294A1 (es)
MX (1) MXPA04004132A (es)
WO (1) WO2003065974A2 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2231973T3 (es) * 1997-03-17 2005-05-16 Abbott Laboratories Medicamento antiangiogenico destinado para el tratamiento del cancer, artritis y retinopatia.
CZ299639B6 (cs) * 1998-05-22 2008-10-01 Abbott Laboratories Peptidická antiangiogenní léciva
PT1232183E (pt) * 1999-11-22 2006-06-30 Abbott Lab Peptidos possuindo actividade anti-angiogenica
CO5261544A1 (es) * 1999-11-22 2003-03-31 Abbott Lab Peptidos n-alquilados que tienen actividad antiangiogenica

Also Published As

Publication number Publication date
WO2003065974A3 (en) 2004-07-15
JP2005517691A (ja) 2005-06-16
EP1461356A4 (en) 2007-12-12
US20030119746A1 (en) 2003-06-26
EP1461356A2 (en) 2004-09-29
CA2466294A1 (en) 2003-08-14
WO2003065974A2 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
TW200420529A (en) Sulfonamides having antiangiogenic and anticancer activity
DE69905476D1 (en) Phosphonsaürederivate als ptp-1b-inhibitoren
NO20003233L (no) 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler
BG104780A (en) Inhibitors of phospholipase enzymes
MXPA05006196A (es) Compuestos y metodos para el tratamiento o prevencion de infecciones por flavivirus.
MXPA04002167A (es) Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
AU2002360592A8 (en) Inhibitors of hepatitis c virus
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
MXPA04004134A (es) Tri-, tetra-, y pentapeptidos que tienen actividad antiangiogenica.
EP0932613A4 (en) EXPRESSION BLOCKING OF VIRULENT FACTORS IN S. AUREUS
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.
MXPA02000330A (es) Pirrolidinas y piperidinas neurotroficas y composiciones y metodos relacionados.
WO2004054513A3 (en) Methods and compositions for treating and preventing ear infections
WO2004034961A3 (en) Antimicrobial agents and uses thereof
MXPA04004132A (es) Hexa-, hepta-, y octapeptidos que tienen actividad antiangiogenica.
WO2003072053A3 (en) Compounds for treatment of copper overload
MXPA04004131A (es) Hexa-, hepta-, y octapeptidos que tienen actividad antiangiogenica.
AU2002231777A1 (en) Use of mglur5 antagonists for the treatment of pruritic conditions
MXPA04004133A (es) Di-, tri- y tetra-peptidos que tienen actividad antiangiogenica.
AUPP345098A0 (en) Novel anti-fibrinolytic agents
MXPA04004135A (es) Tetra-, penta-, hexa y heptapeptidos con actividad antiangiogenica.
HK1061355A1 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
IL164389A0 (en) Methods and compositions for killing spores
ATE259361T1 (de) Benzothiophenverbindungen, zwischenprodukte, zusammensetzungen und methode

Legal Events

Date Code Title Description
FA Abandonment or withdrawal